NCT02147418View on ClinicalTrials.gov

Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 25, 2015

Primary Completion Date

May 8, 2024

Study Completion Date

July 25, 2024

Conditions

Oropharyngeal Cancer

Trial Locations (1)

87131-0001

University of New Mexico Cancer Center, Albuquerque

All Listed Sponsors

lead

New Mexico Cancer Research Alliance

OTHER

NCT02147418 - Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter